Repetitive Transcranial Magnetic Stimulation for Lower Limb Spasticity in Multiple Sclerosis Patients
Repetitive Transcranial Magnetic Stimulation Boosted Exercise Therapy for Lower Limb Spasticity in Multiple Sclerosis Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Ljubica Konstantinovic
- Phone Number: 063323996
- Email: ljubica.konstantinovic@med.bg.ac.rs
Study Locations
-
-
-
Belgrade, Serbia, 11000
- Clinic for rehabilitation dr Miroslav Zotovic Faculty of Medicine University of Belgrade
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Confirmed clinical form of SPMS and PPMS (established on the basis of the revised McDonald criteria)
- EDDS score 2-6.5
- lower limb spasticity caused by MS
- 18 years ≥age of the patient ≤ 65. years
Exclusion Criteria:
- clinical worsening of the disease over the past 30 days,
- the presence of pregnancy, dementia, alcoholism, history of loss of consciousness, epilepsy, metal objects in the head, pacemakers and other electronic devices in the body at a distance of 20cm from the top of the patients head, serious associate diseases (malignancy, heart disease).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Transcranial magnetic stimulation therapy
Group of patients treated with rTMS low than 5Hz
|
TMS 1Hz under the motor zone of cortex.
|
|
Active Comparator: Conventional exercise treatment
Group of patients treated with conventional exercise
|
Exercise will be administrated in a conventional way.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
muscle tone measured by Modified Ashworth Scale (MAS)
Time Frame: 3 weeks
|
3 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
impact of leg spasticity on daily activities measured by Multiple Sclerosis Spasticity Scale 88 (MSSS-88)
Time Frame: 3 weeks
|
3 weeks
|
|
Activities of daily living measured by Barthel Index
Time Frame: 3 weeks
|
3 weeks
|
|
Walking mobility measured by Timed 25 Foot Walk test
Time Frame: 3 weeks
|
3 weeks
|
|
Quality of life measured by Multiple Sclerosis Quality of Life 54 (MSQoL54).
Time Frame: 3 weeks
|
3 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimated)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LK-5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.